{{Underlinked|date=May 2016}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 413515463
| IUPAC_name = (6''R'',7''R'')-7-<nowiki>[[</nowiki>2-(Difluoromethylsulfanyl)acetyl]amino]-3-<nowiki>[[</nowiki>1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Flomoxef.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|flomoxef}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 99665-00-6
| CAS_supplemental =  
| ATC_prefix = J01
| ATC_suffix =  DC14
| ATC_supplemental =  
| PubChem = 65864
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = V9E5U5XF42
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07963
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 15413
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 59274

<!--Chemical data-->
| chemical_formula =  
| C=15 | H=18 | F=2 | N=6 | O=7 | S=2 
| molecular_weight = 496.46 g/mol
| smiles = CO[C@@]1([C@@H]2N(C1=O)C(=C(CO2)CSc3nnnn3CCO)C(=O)O)NC(=O)CSC(F)F
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C15H18F2N6O7S2/c1-29-15(18-8(25)6-31-13(16)17)11(28)23-9(10(26)27)7(4-30-12(15)23)5-32-14-19-20-21-22(14)2-3-24/h12-13,24H,2-6H2,1H3,(H,18,25)(H,26,27)/t12-,15+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = UHRBTBZOWWGKMK-DOMZBBRYSA-N
}}

'''Flomoxef''' ([[International Nonproprietary Name|INN]]) is an [[oxacephem]] antibiotic.

It has been classified as second-generation<ref name="pmid18401677">{{cite journal |vauthors=Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S |title=Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration |journal=Gen Thorac Cardiovasc Surg |volume=56 |issue=4 |pages=163–9 |date=April 2008 |pmid=18401677 |doi=10.1007/s11748-007-0208-5 }}</ref> and fourth-generation.<ref name="pmid1783441">{{cite journal |vauthors=Ito M, Ishigami T |title=The meaning of the development of flomoxef and clinical experience in Japan |journal=Infection |volume=19 Suppl 5 |issue= |pages=S253–7 |year=1991 |pmid=1783441 |doi= 10.1007/bf01645536|url=}}</ref>

==References==
{{reflist}}

{{Cell wall disruptive antibiotics}}

[[Category:Cephalosporin antibiotics]]
[[Category:Tetrazoles]]
[[Category:Alcohols]]
[[Category:Sulfides]]
[[Category:Carboxylic acids]]
[[Category:Lactams]]
[[Category:Ethers]]
[[Category:Carboxamides]]
[[Category:Organofluorides]]


{{antibiotic-stub}}